rofecoxib has been researched along with Carcinoma, Small Cell in 1 studies
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, M | 1 |
| Wang, JH | 1 |
| Coffey, JC | 1 |
| Qadri, SS | 1 |
| O'Donnell, A | 1 |
| Aherne, T | 1 |
| Redmond, HP | 1 |
1 other study available for rofecoxib and Carcinoma, Small Cell
| Article | Year |
|---|---|
Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines.
Topics: Analysis of Variance; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small | 2007 |